Sumgen Biotech

时迈药业

Sumgen Biotech

Biotech/Healthcare

Shimai Pharmaceuticals is an innovative developer of antibody therapeutics for cancer and immune diseases. Its business model centers on wholly novel drugs and combines end-product development with interim-stage asset transfers and technology-platform licensing.

Latest round: Series C (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-02-01